Search results
Results from the WOW.Com Content Network
M8370/3 Adrenal cortical carcinoma (C74.0) Adrenal cortical adenocarcinoma; Adrenal cortical tumor, malignant; M8371/0 Adrenal cortical adenoma, compact cell (C74.0) M8372/0 Adrenal cortical adenoma, pigmented (C74.0) Black adenoma; Pigmented adenoma; M8373/0 Adrenal cortical adenoma, clear cell (C74.0) M8374/0 Adrenal cortical adenoma ...
Metastasis to one or both adrenal glands is the most common form of malignant adrenal lesion, and the second most common adrenal tumor after benign adenomas. [4] Primary tumors in such cases are most commonly from lung cancer (39%), breast cancer (35%), malignant melanoma , gastrointestinal tract cancer , pancreas cancer , and renal cancer .
Adrenocortical carcinoma (ACC) is an aggressive cancer originating in the cortex (steroid hormone-producing tissue) of the adrenal gland.. Adrenocortical carcinoma is remarkable for the many hormonal syndromes that can occur in patients with steroid hormone-producing ("functional") tumors, including Cushing's syndrome, Conn syndrome, virilization, and feminization.
Neuroblastoma often spreads to other parts of the body before any symptoms are apparent, and 50 to 60% of all neuroblastoma cases present with metastases. [8] The most common location for neuroblastoma to originate (i.e., the primary tumor) is in the adrenal glands. This occurs in 40% of localized tumors and in 60% of cases of widespread disease.
Ganglioneuroma of the adrenal gland. Because ganglioneuromas are benign, treatment may not be necessary, as it would expose patients to more risk than leaving it alone. [citation needed] If there are symptoms or major physical deformity, treatment usually consists of surgery to remove the tumor. [citation needed]
The most common extra-adrenal sites of metastases are the lymph nodes, lung, liver, and bone. [135] There have been several studied risk factors associated with the development of metastatic disease — while the patients genetic background plays an important role, the initial age of presentation and size of the tumor lead to negative outcomes ...
Clinically, the majority of diagnosed CNS metastasis are derived from well-known primary tumours, while still, about 5-10% are from unknown sources. [8] Since most cancers can progress towards CNS metastasis despite multimodal treatments, it is a significant risk for patients with systemic cancer.
Metastases to the liver can be treated by several types of hepatic artery treatments based on the observation that tumor cells get nearly all their nutrients from the hepatic artery, while the normal cells of the liver get about 70–80 percent of their nutrients and 50% their oxygen supply from the portal vein, and thus can survive with the ...